Antibody‐dependent cellular cytotoxicity of cetuximab against tumor cells with wild‐type or mutant epidermal growth factor receptor
H Kimura, K Sakai, T Arao, T Shimoyama… - Cancer …, 2007 - Wiley Online Library
Cetuximab (Erbitux, IMC‐C225) is a monoclonal antibody targeted to the epidermal growth
factor receptor (EGFR). To clarify the mode of antitumor action of cetuximab, we examined …
factor receptor (EGFR). To clarify the mode of antitumor action of cetuximab, we examined …
Antibody-dependent cellular cytotoxicity of cetuximab against tumor cells with wild-type or mutant epidermal growth factor receptor.
H Kimura, K Sakai, T Arao, T Shimoyama… - Cancer …, 2007 - europepmc.org
Cetuximab (Erbitux, IMC-C225) is a monoclonal antibody targeted to the epidermal growth
factor receptor (EGFR). To clarify the mode of antitumor action of cetuximab, we examined …
factor receptor (EGFR). To clarify the mode of antitumor action of cetuximab, we examined …
[引用][C] Antibody-dependent cellular cytotoxicity of cetuximab against tumor cells with wild-type or mutant epidermal growth factor receptor
H KIMURA, K SAKAI, T ARAO, T SHIMOYAMA… - Cancer …, 2007 - pascal-francis.inist.fr
Antibody-dependent cellular cytotoxicity of cetuximab against tumor cells with wild-type or
mutant epidermal growth factor receptor CNRS Inist Pascal-Francis CNRS Pascal and …
mutant epidermal growth factor receptor CNRS Inist Pascal-Francis CNRS Pascal and …
Antibody-dependent cellular cytotoxicity of cetuximab against tumor cells with wild-type or mutant epidermal growth factor receptor
H Kimura, K Sakai, T Arao, T Shimoyama… - Cancer …, 2007 - pubmed.ncbi.nlm.nih.gov
Cetuximab (Erbitux, IMC-C225) is a monoclonal antibody targeted to the epidermal growth
factor receptor (EGFR). To clarify the mode of antitumor action of cetuximab, we examined …
factor receptor (EGFR). To clarify the mode of antitumor action of cetuximab, we examined …
Antibody‐dependent cellular cytotoxicity of cetuximab against tumor cells with wild‐type or mutant epidermal growth factor receptor
H Kimura, K Sakai, T Arao, T Shimoyama, T Tamura… - Cancer Science, 2007 - cir.nii.ac.jp
抄録< jats: p> Cetuximab (Erbitux, IMC‐C225) is a monoclonal antibody targeted to the
epidermal growth factor receptor (EGFR). To clarify the mode of antitumor action of …
epidermal growth factor receptor (EGFR). To clarify the mode of antitumor action of …
[引用][C] Antibody-dependent cellular cytotoxicity of cetuximab against tumor cells with wild-type or mutant epidermal growth factor receptor
K Hideharu, S Kazuko, A Tokuzo, S Tatsu, T Tomohide… - Cancer science, 2007 - cir.nii.ac.jp
Antibody-dependent cellular cytotoxicity of cetuximab against tumor cells with wild-type or
mutant epidermal growth factor receptor | CiNii Research CiNii 国立情報学研究所 学術情報 …
mutant epidermal growth factor receptor | CiNii Research CiNii 国立情報学研究所 学術情報 …